参考文献/References:
[1] Starke RM, Komotar RJ, Hickman ZL, et al. Clinical fea-
tures, surgical treatment, and long-term outcome in adult
patients with moyamoya disease [J]. J Neurosurg, 2009, 111
(5): 936-942.
[2] He Y, Zhou Q, He M. An asymptomatic Moyamoya disease:
autopsy case and literature review [J]. Am J Forensic Med
Pathol, 2010, 31(1): 77-79.
[3] Yim SH, Cho CB, Joo WI, et al. Prevalence and epidemio-
logical features of moyamoya disease in Korea [J]. J Cere-
brovasc Endovasc Neurosurg, 2012, 14(2): 75-78.
[4] Kuroda S, Houkin K. Moyamoya disease: current concepts
and future perspectives [J]. Lancet Neurol, 2008, 7(11):
1056-1066.
[5] Kawaguchi S, Sakaki T, Morimoto T, et al. Characteristics of
intracranial aneurysms associated with moyamoya disease
[J]. Acta Neurochir (Wien), 1996, 138(11): 1287-1294.
[6] 陈 东,林民辉,吴永峻,等. CT、MRA及DSA对成人型烟
雾病的诊断价值[J]. 影像诊断与介入放射学,2009,18
(3):117-119.
[7] 陈 军,李爱民,陈 震,等. 血管重建手术与保守治疗出
血型烟雾病的疗效分析[J]. 中国微创外科杂志,2015,15
(12):1084-1087.
[8] 陈 兵,吉 青,郝解贺. 手术与保守治疗烟雾病病人预
后比较的meta分析[J]. 临床医药实践,2015,24(8):578-
582.
[9] Liu X, Zhang D, Shuo W, et al. Long term outcome after
conservative and surgical treatment of haemorrhagic moya-
moya disease [J]. J Neurol Neurosurg Psychiatry, 2013, 84
(3): 258-265.
[10] 高登科,张 东,王 嵘,等. 出血型烟雾病的临床特点及
治疗现状[J]. 中国卒中杂志,2011,6(2):163-167.
[11] 杨怀滔,张正善,段 炼. 合并颅内动脉瘤的烟雾病:临床
特征、出血危险因素和治疗转归[J]. 国际脑血管病杂志,
2015,15(2):102-106.
[12] 张晓斌,黄理金,文 军,等. 出血性烟雾病合并动脉瘤的
治疗和预后[J]. 中华神经外科杂志,2015,31(1):22-26.
[13] 王 英,于群涛,闫志慧,等. 烟雾病伴血流相关性动脉瘤
诊治探讨[J]. 中华神经医学杂志,2013,12(4):412-414.
[14] 姜大宇,吕加希,李佑祥,等. 烟雾病伴血流相关性动脉瘤
介入治疗体会[J]. 中华神经外科疾病研究杂志,2013,12
(5):454-455.
[15] Zhang L, Xu K, Zhang Y, et al. Treatment strategies for
aneurysms associated with moyamoya disease [J]. Int J Med
Sci, 2015, 12(3): 234.
[16] Kodama N, Sato M, Sasaki T. Treatment of ruptured cerebral
aneurysm in moyamoya disease [J]. Surg Neurol, 1996, 46
(1): 62-66.
相似文献/References:
[1]李 琴 袁辉胜.高压氧治疗抢救烟雾病合并一氧化碳中毒1例[J].中国临床神经外科杂志,2016,(07):441.[doi:10.13798/j.issn.1009-153X.2016.07.019]
[2]张登文 邓剑平 张 涛 陈 虎 赵振伟.颞浅动脉-颞浅筋膜-脑贴敷术治疗烟雾病疗效观察[J].中国临床神经外科杂志,2015,(06):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
ZHANG Deng-wen,DENG Jian-ping,ZHANG Tao,et al.Curative effect of encephalo-superficial temporal artery-superficial temporal fascia flap-synangiosis on Moyamoya disease (report of 31 cases)[J].,2015,(04):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
[3]刘锡禹 张正善 赵 峰 韩 聪 李 斌 段 炼.烟雾病合并后循环病变致继发枕叶梗死的相关危险因素分析[J].中国临床神经外科杂志,2015,(07):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
LIU Xi-yu,ZHANG Zheng-shan,ZHAO Feng,et al.Analysis of the risk factors related to occipital lobe infarction induced by Moyamoya disease complicated with posterior circulation lesions[J].,2015,(04):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
[4]黄 坦 黄书岚 陈谦学.颞浅动脉-大脑中动脉搭桥术治疗成人烟雾病[J].中国临床神经外科杂志,2015,(05):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
HUANG Tan,HUANG Shu-lan,CHEN Qian-xue..Treatment of Moyamoya disease with superficial temporal artery-middle cerebral artery bypass in adults[J].,2015,(04):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
[5]马廉亭.建议把“烟雾病”诊断还原为“脑基底异常血管网”症[J].中国临床神经外科杂志,2017,(07):449.[doi:10.13798/j.issn.1009-153X.2017.07.001]
[6]陈姣红 刘东媛 张红波 李明昌 熊晓星 陈谦学.成人出血型烟雾病围手术期护理观察[J].中国临床神经外科杂志,2018,(06):437.[doi:10.13798/j.issn.1009-153X.2018.06.020]
[7]杨允东 李永强.多普勒超声血流动力学监测在烟雾病STA-MCA吻合术中的应用[J].中国临床神经外科杂志,2018,(07):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
YANG Yun-dong,LI Yong-qiang..Change in the STA hymodynamics monitored by color Doppler ultrasound before and after STA-MCA anastomosis in patients with Moyamoya disease[J].,2018,(04):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
[8]欧阳光 黄书岚.烟雾病的现况及研究进展[J].中国临床神经外科杂志,2018,(08):564.[doi:doi:10.13798/j.issn.1009-153X.2018.08.020]
[9]黄彩菲,刘雅静,张红波,等.烟雾病血运重建术中配合及护理[J].中国临床神经外科杂志,2018,(10):692.[doi:10.13798/j.issn.1009-153X.2018.10.018]
[10]孙登彬 糜相明 刘运振.磁共振灌注成像在烟雾病血管重建术中的临床应用价值[J].中国临床神经外科杂志,2019,(02):78.[doi:10.13798/j.issn.1009-153X.2019.02.005]
SUN Deng-bin,MI Xiang-ming,LIU Yun-zhen. Department of Neurosurgery,et al.Clinical value of brain MR perfusion-weighted imaging before and after revascularization in patients with moyamoya disease[J].,2019,(04):78.[doi:10.13798/j.issn.1009-153X.2019.02.005]